Evidence map›Paper›PMID 41685898›Full record

ArticleMicrobiology spectrum2026

Profound cell wall remodeling in

Farnaz Daneshnia, Liuyang Cai, Deepika Gunasekaran, Isha Gautam, Austin M Perry, Pegah Mosharaf Ghahfarokhy, Arefeh Ebadati, Julieta Munoz, Dorian Padilla, Süleyha Hilmioglu-Polat and 19 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Farnaz DaneshniaInstitute of Biodiversity and Ecosystem Dynamics (IBED), University of Amsterdam, Amsterdam, Netherlands.ORCID 0000-0002-8782-2036
Liuyang CaiDepartment of Dermatology, Shanghai Key Laboratory of Molecular Medical Mycology, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China.
Deepika GunasekaranDepartment of Molecular and Cell Biology, School of Natural Sciences, University of California Merced, Merced, California, USA.
Isha GautamDepartment of Chemistry, Michigan State University, East Lansing, Michigan, USA.
Austin M PerryDepartment of Molecular and Cell Biology, School of Natural Sciences, University of California Merced, Merced, California, USA.
Pegah Mosharaf GhahfarokhyDepartment of Molecular and Cell Biology, School of Natural Sciences, University of California Merced, Merced, California, USA.
Arefeh EbadatiDepartment of Molecular and Cell Biology, School of Natural Sciences, University of California Merced, Merced, California, USA.
Julieta MunozDepartment of Molecular and Cell Biology, School of Natural Sciences, University of California Merced, Merced, California, USA.
Dorian PadillaDepartment of Molecular and Cell Biology, School of Natural Sciences, University of California Merced, Merced, California, USA.
Süleyha Hilmioglu-PolatDepartment of Medical Microbiology, Ege University Faculty of Medicine, Izmir, Turkey.ORCID 0000-0001-8850-2715
Shenglin MeiFralin Biomedical Research Institute, Virginia Tech FBRI21 Cancer Research Center, Washington, DC, USA.
Daniel J FloydDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Miquel Àngel Schikora-TamaritLife Sciences Programme, Supercomputing Center (BSC-CNS), Barcelona, Spain.
Diego FuentesLife Sciences Programme, Supercomputing Center (BSC-CNS), Barcelona, Spain.
Maria Artigues-LleixàLife Sciences Programme, Supercomputing Center (BSC-CNS), Barcelona, Spain.
Louise A WalkerSchool of Medicine, Medical Sciences and Nutrition, Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom.ORCID 0000-0002-2236-8776
Samuel M GonçalvesSchool of Medicine, Life and Health Sciences Research Institute (ICVS), University of Minho, Braga, Portugal.
Mostafa SalehiDepartment Industrial Engineering Faculty of K.N, KN Toosi University of Technology, Tehran, Iran.
Agostinho CarvalhoSchool of Medicine, Life and Health Sciences Research Institute (ICVS), University of Minho, Braga, Portugal.ORCID 0000-0001-8935-8030
Jigar V DesaiCenter for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.ORCID 0000-0002-8823-0796
David S PerlinCenter for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.ORCID 0000-0002-1268-5524
Carol A MunroSchool of Medicine, Medical Sciences and Nutrition, Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom.ORCID 0000-0003-0761-1755
Alex HopkeDepartment of Biomedical Sciences, East Tennessee State University Quillen College of Medicine, Center of Excellence in Inflammation, Infectious Disease and Immunity, East Tennessee State University, Johnson City, Tennessee, USA.
Tuo WangDepartment of Chemistry, Michigan State University, East Lansing, Michigan, USA.ORCID 0000-0002-1801-924X
Toni GabaldónLife Sciences Programme, Supercomputing Center (BSC-CNS), Barcelona, Spain.
Wenjie FangDepartment of Dermatology, Shanghai Key Laboratory of Molecular Medical Mycology, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China.ORCID 0000-0002-6406-5095
Clarissa J NobileDepartment of Molecular and Cell Biology, School of Natural Sciences, University of California Merced, Merced, California, USA.ORCID 0000-0003-0799-6499
Michael K MansourDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.ORCID 0000-0001-8892-8695
Amir ArastehfarDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.ORCID 0000-0002-4361-4841

Funding

Genetic regulation of inter- and intra-species microbial community formationR35GM156045 · NIGMS · UNIVERSITY OF CALIFORNIA, MERCED · PI Clarissa Jane Nobile · 2025 to 2026
$995k
National Institute of Allergy and Infectious Diseases K22AI163399National Institute of Allergy and Infectious Diseases R01AI132638, R01AI176658National Institute of Allergy and Infectious Diseases R01AI173270NIGMS NIH HHS R35GM156045
6 · The paper itself

Abstract

Antifungal tolerance can promote the emergence of resistance yet often incurs fitness costs for fungal pathogens. How tolerant populations compensate for these deficits and how they may be therapeutically targeted remain poorly understood. Here, we investigate four sequential

Indexed as

Antifungal AgentsCandida parapsilosisCandidemiaCandidiasisCell WallEchinocandinsAmphotericin BAnimalsBiofilmsDrug Resistance, FungalHumansMacrophagesMiceMicrobial Sensitivity TestsAmphotericin BAntifungal AgentsEchinocandinsliposomal amphotericin Bbiofilmscell wall remodelingechinocandinsimmune evasionmacrophage polarizationpolyenesresistancetolerance

Identifiers

PMID41685898
PMCPMC13055393

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.